"The FDA’s precautionary approach may pose a greater threat to consumer health than the harms it seeks to prevent." http://t.co/AfBM9lshTn— Rock Health (@Rock_Health) January 16, 2014
Latest @US_FDA|@23andMe @NatureMagazine "we urge the FDA to let consumer #genomics testing proceed" http://t.co/RoTFJUp4Z3 @genomes2people
— Eric Topol (@EricTopol) January 15, 2014
Andrea Patenaude (http://t.co/nUbQNe2k8I) describes prophylactic mastectomy as women "trading physical normalcy for emotional normalcy"The Chinese in my family (Malaysia) say that care models (and FDA) in the U.S. still reward treatment, though; not prevention. In China (Asia), care models reward prevention...
— Robert C. Green (@genomes2people) September 10, 2013
.@EricTopol @US_FDA @23andMe @genomes2people Care models and FDA in the US reward Tx; not prevention. In Asia, care models reward prevention
— CATHERINE COSTE (@cathcoste) January 15, 2014